Stock Market Live May 4, 2026: S&P 500 (SPY) Sinks on Iran Uncertainty Again

Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Chris Lange | Mar 6, 2019 at 1:40 PM EST

Why Bio-Path Shares Nearly Tripled

Bio-Path shares made an incredible run on Wednesday after the company announced interim results from its mid-stage leukemia trial.

Jon C. Ogg | Mar 6, 2019 at 6:35 AM EST

How Intercept Pharma Shares Could See Blockbuster Drug and See Its Shares Double

Intercept Pharmaceuticals was last seen trading higher after the company's financial reporting. While numbers are always important to see, a…

Chris Lange | Mar 4, 2019 at 9:50 AM EST

Why Ascendis Pharma Shares Hit an All-Time High

Ascendis Pharma shares spiked early Monday as the result of positive top-line results from its late-stage growth hormone study in…

Chris Lange | Mar 4, 2019 at 8:30 AM EST

Are Nightstar Shareholders Getting Enough in the Buyout?

Nightstar Therapeutics shares exploded early on Monday after it was announced that the firm would be acquired by Biogen. The…

Chris Lange | Mar 2, 2019 at 8:45 AM EST

Wedbush’s Top Biotech Picks Ahead of AACR Annual Meeting

Abstracts have been released for the companies presenting at the American Association for Cancer Research annual meeting, and Wedbush has…

Chris Lange | Mar 1, 2019 at 11:30 AM EST

What Lexicon Pharma Could Mean for the Future of Diabetes

Lexicon shares jumped on Friday after the European Medicines Agency’s Committee for Medicinal Products for Human Use adopted a positive…

Chris Lange | Mar 1, 2019 at 10:15 AM EST

Is Immunogen Done After This Ovarian Cancer Study?

ImmunoGen shares were halved on Friday after the firm reported late-stage results from its ovarian cancer study.

Douglas A. McIntyre | Mar 1, 2019 at 6:30 AM EST

Fast Food Much Less Healthy Than 3 Decades Ago

Fast food is usually characterized as unhealthy, with high amounts of fat, salt and sugar. A new study shows that…

Chris Lange | Feb 28, 2019 at 11:35 AM EST

What’s Next for Horizon Pharma After This Late-Stage TED Trial

Horizon Pharma shares exploded on Thursday after the firm announced results from its late-stage trial evaluating teprotumumab for the treatment…

Chris Lange | Feb 28, 2019 at 8:35 AM EST

Short Sellers Can’t Make Up Their Minds on Major Biotechs

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The February 15 short interest data…

Chris Lange | Feb 28, 2019 at 8:30 AM EST

Major Pharma Sees Tremendous Rise in Short Interest

The February 15 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Feb 27, 2019 at 11:25 AM EST

Why Tandem Diabetes Shares Are Soaring

Tandem Diabetes shares soared after it reported better-than-expected quarterly results and announced management changes.

Chris Lange | Feb 26, 2019 at 10:25 AM EST

Meet Zynerba’s Newest Patent

Zynerba Pharmaceuticals shares jumped on Tuesday after the company announced that it has received a key patent from the U.S.…

Jon C. Ogg | Feb 25, 2019 at 5:59 PM EST

M&A Verdict: Danaher Gets Better Side of the Deal Than GE in Life Sciences Unit Sale

Investors and speculators just love a good merger and acquisition story. The story of General Electric selling its Life Sciences…

Paul Ausick | Feb 25, 2019 at 1:35 PM EST

FDA Warns Against Thermography for Breast Cancer Screening

The FDA has warned a California company against marketing its thermography device as a stand-alone test for breast cancer and…

1 … 104 105 106 107 108 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Why Bio-Path Shares Nearly Tripled

How Intercept Pharma Shares Could See Blockbuster Drug and See Its Shares Double

Why Ascendis Pharma Shares Hit an All-Time High

Are Nightstar Shareholders Getting Enough in the Buyout?

Wedbush’s Top Biotech Picks Ahead of AACR Annual Meeting

What Lexicon Pharma Could Mean for the Future of Diabetes

Is Immunogen Done After This Ovarian Cancer Study?

Fast Food Much Less Healthy Than 3 Decades Ago

What’s Next for Horizon Pharma After This Late-Stage TED Trial

Short Sellers Can’t Make Up Their Minds on Major Biotechs

Major Pharma Sees Tremendous Rise in Short Interest

Why Tandem Diabetes Shares Are Soaring

Meet Zynerba’s Newest Patent

M&A Verdict: Danaher Gets Better Side of the Deal Than GE in Life Sciences Unit Sale

FDA Warns Against Thermography for Breast Cancer Screening

Stock Market Live May 4, 2026: S&P 500 (SPY) Sinks on Iran Uncertainty Again

The Triple-Tax-Free Account Doctors Are Maxing Before Their 401(k) and Most Plans Won’t Tell You About

Can PennantPark’s First-Lien Loans Keep Funding Income Payments

Bitcoin Price Prediction as BTC Breaks Above $80,000

The Triple-Tax-Free Account Doctors Are Maxing Before Their 401(k) and Most Plans Won't Tell You About

Ditch Starbucks and DoorDash, George Kamel Says. How Cheap Appliances Can Replace Your Takeout Budget

The Triple-Tax-Free Account Doctors Are Maxing Before Their 401(k) and Most Plans Won’t Tell You About

Stock Market Live May 4, 2026: S&P 500 (SPY) Sinks on Iran Uncertainty Again

Health and Healthcare Articles

All Health and Healthcare Articles

Why Bio-Path Shares Nearly Tripled

How Intercept Pharma Shares Could See Blockbuster Drug and See Its Shares Double

Why Ascendis Pharma Shares Hit an All-Time High

Are Nightstar Shareholders Getting Enough in the Buyout?

Wedbush’s Top Biotech Picks Ahead of AACR Annual Meeting

What Lexicon Pharma Could Mean for the Future of Diabetes

Is Immunogen Done After This Ovarian Cancer Study?

Fast Food Much Less Healthy Than 3 Decades Ago

What’s Next for Horizon Pharma After This Late-Stage TED Trial

Short Sellers Can’t Make Up Their Minds on Major Biotechs

Major Pharma Sees Tremendous Rise in Short Interest

Why Tandem Diabetes Shares Are Soaring

Meet Zynerba’s Newest Patent

M&A Verdict: Danaher Gets Better Side of the Deal Than GE in Life Sciences Unit Sale

FDA Warns Against Thermography for Breast Cancer Screening

Stock Market Live May 4, 2026: S&P 500 (SPY) Sinks on Iran Uncertainty Again

The Triple-Tax-Free Account Doctors Are Maxing Before Their 401(k) and Most Plans Won’t Tell You About

Can PennantPark’s First-Lien Loans Keep Funding Income Payments

Bitcoin Price Prediction as BTC Breaks Above $80,000

Featured Reads

The Triple-Tax-Free Account Doctors Are Maxing Before Their 401(k) and Most Plans Won't Tell You About

Ditch Starbucks and DoorDash, George Kamel Says. How Cheap Appliances Can Replace Your Takeout Budget